Blue Star
- Market Cap
- ₹36,826 Cr
- P/E
- 68.94
Key Fundamentals
SmallcapConsumer DurablesConsumer DiscretionaryPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 21.20%
- Debt to Equity
- 0.22
- EPS (TTM)
- ₹25.98
- Book Value
- ₹169.59
- Market Cap
- ₹36,826 Cr
- P/E (TTM)
- 68.94
- P/B
- 10.56
- ROE
- 17.20%
- Dividend Yield
- 0.48%
- EBITDA
- ₹992 Cr
- 52W High
- ₹2,029.60
- 52W Low
- ₹1,432.30
- Day Range
- ₹1,750.40 – ₹1,820.00
- Volume
- 11,44,409
Peer Comparison
Consumer Discretionary › Consumer Durables › Household Appliances
| 1,740.70 | 61.38 | 1,18,154 | 13.41 | 0.00% | 24.70% | 32.30% | 26,781 | 1,925 | |
| 1,235.00 | 87.40 | 40,864 | 6.05 | 0.35% | 6.10% | 9.04% | 15,339 | 458 | |
| 1,791.00 | 68.94 | 36,826 | 10.56 | 0.52% | 17.20% | 21.20% | 13,306 | 535 | |
| 6,740.50 | 485.63 | 23,772 | 5.44 | 0.00% | 5.99% | 10.30% | 13,605 | 90 | |
| 223.40 | — | 14,385 | 4.44 | 1.45% | 10.30% | 19.00% | 7,698 | −189 | |
| 303.15 | 32.18 | 13,245 | 5.17 | 0.51% | 14.40% | 18.40% | 6,822 | 411 | |
| 819.50 | 44.30 | 10,397 | 2.46 | 0.61% | 7.71% | 10.70% | 8,554 | 235 | |
| Median 7 companies | 1,235.00 | 65.16 | 23,772 | 5.44 | 0.51% | 10.30% | 18.40% | 13,306 | 411 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 44
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 27
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 29
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 43
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 50
- Average
- Trend strength, vol-adjusted 12% weight
- Ownership
- 55
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company has delivered good profit growth of 49.6% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 33.0%
Weaknesses
1- Stock is trading at 10.6 times its book value
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 3 | 12 |
| Oscillators | Bearish | 4 | 3 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 72.92
- Bearish
- MACD (12,26,9)
- 38.27
- Bullish
- SMA (50)
- 1,566.23
- Bullish
- SMA (200)
- 1,667.12
- Bullish
As of
Analyst Rating
14 of 27 analysts rate Buy, 8 Hold, 5 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +12.56% |
|---|---|
| 5Y | +23.80% |
| 3Y | +15.85% |
| 1Y | +3.63% |
| TTM | +8.80% |
Net profit
| 10Y | +17.40% |
|---|---|
| 5Y | +39.15% |
| 3Y | +9.54% |
| 1Y | −10.83% |
| TTM | −2.01% |
Operating cash flow
| 10Y | −4.99% |
|---|---|
| 5Y | −15.14% |
| 3Y | −14.57% |
| 1Y | −77.62% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +3.12 pp |
|---|---|
| 5Y | +1.89 pp |
| 3Y | +1.25 pp |
| 1Y | +0.18 pp |
| TTM | −0.17 pp |
Revenue by year
| Mar 2017 | ₹4,385 Cr |
|---|---|
| Mar 2018 | ₹4,639 Cr |
| Mar 2019 | ₹5,235 Cr |
| Mar 2020 | ₹5,360 Cr |
| Mar 2021 | ₹4,264 Cr |
| Mar 2022 | ₹6,064 Cr |
| Mar 2023 | ₹7,977 Cr |
| Mar 2024 | ₹9,685 Cr |
| Mar 2025 | ₹11,968 Cr |
| Mar 2026 | ₹12,402 Cr |
Net profit by year
| Mar 2017 | ₹123 Cr |
|---|---|
| Mar 2018 | ₹144 Cr |
| Mar 2019 | ₹190 Cr |
| Mar 2020 | ₹144 Cr |
| Mar 2021 | ₹101 Cr |
| Mar 2022 | ₹168 Cr |
| Mar 2023 | ₹401 Cr |
| Mar 2024 | ₹414 Cr |
| Mar 2025 | ₹591 Cr |
| Mar 2026 | ₹527 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Blue Star Ltd trades at ₹1,764 as of 2026-11-19 with a market cap of ₹36,270 crore. The company has delivered strong long-term profit and sales compounding but currently commands a premium valuation at a P/E of 67.9x and P/B of 10.4x, while maintaining a conservative balance sheet with a debt-to-equity ratio of 0.24.
- Exceptional 5-year compounded profit growth of 50%, reflecting strong earnings momentum and operational leverage over the medium term
- Robust 10-year compounded sales growth of 13% and 3-year compounded sales growth of 16%, indicating consistent top-line expansion across cycles
- Healthy 5-year compounded profit CAGR of 49.6%, demonstrating the company's ability to scale profits significantly faster than revenue
- Conservative balance sheet with debt-to-equity of just 0.24, providing financial flexibility for future capacity expansion or acquisitions
- ROCE of 20.9% signals efficient capital deployment and strong underlying business economics
- Consistent ROE averaging 19% over the last 10 years and 20% over 5 years, reflecting durable return generation for shareholders
- Healthy dividend payout ratio of 33.0%, balancing reinvestment needs with shareholder returns at a dividend yield of 0.52%
- Long-term stock CAGR of 22% over 10 years and 26% over 5 years demonstrates sustained wealth creation for patient investors
- TTM compounded profit growth has dropped to 0%, a sharp deceleration from the 27% seen over 3 years, raising concerns about near-term earnings momentum
- Stock trades at 10.4x book value, well above typical consumer discretionary peers, pricing in aggressive future growth expectations
- TTM compounded sales growth has slowed to 9% compared to 16% over 3 years and 24% over 5 years, suggesting a potential deceleration in revenue momentum
- Stock is down 10% over the past 1 year (stock CAGR of -10%), and trades roughly 13% below its 52-week high of ₹2,029.60, indicating recent price weakness
- Last year ROE of 17% has declined from the 5-year average of 20%, suggesting some compression in return ratios
- Dividend yield of 0.52% offers minimal income cushion relative to the elevated valuation, making total returns highly dependent on capital appreciation
- At a market cap of ₹36,270 crore with TTM EPS of ₹25.98, any earnings miss could trigger a significant de-rating given the stretched multiples
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Blue Star is delivering strong top-line and bottom-line growth with Q2FY27 revenue up 21% and PAT up 25% YoY, supported by robust room AC demand and a promising data center order pipeline. The key risk is sharp margin compression in Unitary Products, where EBIT margin dropped from 6.2% to 2.3% due to material cost pressures. Management's reaffirmation of the 6.5% full-year EBIT margin target implies confidence in a meaningful H2 recovery, making the next quarter critical to watch for margin trajectory.
- Unitary Products margin compression Nov 5
Unitary Products EBIT margin fell sharply to 2.3% from 6.2% YoY in Q2FY27 despite 29.4% revenue growth, indicating significant material cost pressures eroding profitability in the segment.
- Operating profit lags revenue growth Nov 5
Consolidated operating profit rose only 10.5% YoY in Q2FY27 versus 21% revenue growth, reflecting margin pressure from higher input costs.
- Q2FY27 PAT up 25% YoY Oct 29
Consolidated net profit rose 25% YoY to ₹123.91 crore in Q2FY27, with revenue growing 21% to ₹2,930.95 crore driven by strong project execution and room AC demand.
- Data center order pipeline building Nov 5
Management expects data center orders to reach ₹4,000 crore over three years, providing a meaningful growth driver for the EMPS segment.
- Dubai court ruling in favour Oct 31
Dubai Court of Appeal dismissed WJT's annulment application against the ICC award favouring Blue Star, upholding dismissal of an OMR 2.11 crore claim.
- Analyst meet scheduled Nov 19 Nov 16
Blue Star will hold a virtual group meeting with analysts and institutional investors on November 19, 2026.
- Two senior leaders appointed Oct 29
Blue Star appointed Nithianand S and Senthil Thangam as Senior Management Personnel effective November 1, 2026, strengthening supply chain and AC divisions.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,890 | 2,241 | 3,328 | 2,865 | 2,276 | 2,807 | 4,019 | 2,982 | 2,422 | 2,925 | 4,072 | 3,378 | 2,931 |
| Expenses | 1,768 | 2,086 | 3,086 | 2,628 | 2,127 | 2,599 | 3,740 | 2,784 | 2,240 | 2,705 | 3,746 | 3,203 | 2,728 |
| Operating Profit | 123 | 155 | 242 | 238 | 149 | 209 | 279 | 199 | 182 | 220 | 326 | 175 | 203 |
| OPM % | 6% | 7% | 7% | 8% | 7% | 7% | 7% | 7% | 8% | 8% | 8% | 5% | 7% |
| Other Income | 13 | 13 | 12.39 | 24 | 19 | 8.73 | 24 | 16 | 10 | 11.88 | 45 | 20.76 | 15.79 |
| Interest | 18 | 10 | 12 | 8 | 6 | 16 | 19 | 10 | 17 | 22 | 23 | 13 | 17 |
| Depreciation | 23 | 23 | 28 | 28 | 30 | 35 | 35 | 41 | 43 | 46 | 48 | 57 | 68 |
| Exceptional Items | — | — | — | — | — | 12.51 | — | — | — | −56.35 | — | 9.17 | 23.02 |
| PBT | 95 | 134 | 214 | 226 | 131 | 180 | 249 | 163 | 133 | 108 | 300 | 135 | 157 |
| Tax % | 26% | 25% | 25% | 25% | 27% | 26% | 22% | 26% | 25% | 25% | 24% | 24% | 21% |
| Net Profit | 71 | 100 | 160 | 169 | 96 | 132 | 194 | 121 | 99 | 81 | 227 | 103 | 124 |
| EPS (₹) | 3.44 | 4.88 | 7.81 | 8.21 | 4.68 | 6.45 | 9.42 | 5.88 | 4.82 | 3.92 | 11.04 | 4.99 | 6.03 |
| YoY Sales growth | 19 | 25 | 27 | 29 | 20 | 25 | 21 | 4 | 6 | 4 | 1 | 13 | 21 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,182 | 3,798 | 4,385 | 4,639 | 5,235 | 5,360 | 4,264 | 6,064 | 7,977 | 9,685 | 11,968 | 12,402 | 13,306 |
| Expenses | 3,014 | 3,631 | 4,162 | 4,372 | 4,887 | 5,077 | 4,024 | 5,717 | 7,478 | 9,017 | 11,089 | 11,469 | 12,383 |
| Operating Profit | 168 | 167 | 223 | 266 | 348 | 283 | 240 | 347 | 500 | 669 | 879 | 933 | 924 |
| OPM % | 5% | 4.4% | 5% | 6% | 7% | 5% | 6% | 6% | 6% | 7% | 7% | 8% | 7% |
| Other Income | −34 | 66 | 34 | 16.95 | 24.69 | 40 | 62 | 36 | 195 | 44 | 83 | 21 | 70 |
| Interest | 49 | 43 | 38 | 29 | 48 | 29 | 65 | 46 | 55 | 58 | 49 | 72 | 75 |
| Depreciation | 43 | 57 | 61 | 64 | 75 | 88 | 92 | 86 | 85 | 98 | 128 | 179 | 219 |
| Exceptional Items | — | — | — | 5.27 | — | — | — | — | — | — | — | — | — |
| PBT | 43 | 132 | 159 | 196 | 251 | 206 | 145 | 250 | 555 | 557 | 786 | 703 | 700 |
| Tax % | −18% | 21% | 23% | 25% | 17% | 32% | 32% | 33% | 28% | 26% | 25% | 25% | — |
| Net Profit | 54 | 106 | 123 | 144 | 190 | 144 | 101 | 168 | 401 | 414 | 591 | 527 | 534 |
| EPS (₹) | 3.01 | 5.82 | 6.44 | 7.50 | 9.87 | 7.44 | 5.21 | 8.71 | 20.79 | 20.18 | 28.75 | 25.66 | 25.98 |
| Div. Payout % | 83% | 56% | 58% | 67% | 51% | 67% | 38% | 57% | 29% | 35% | 31% | 33% | — |
| Sales growth | 8 | 19 | 15 | 6 | 13 | 2 | −20 | 42 | 32 | 21 | 24 | 4 | 9 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 41 | 41 | 41 | 41 |
| Reserves | 438 | 612 | 738 | 774 | 854 | 763 | 866 | 998 | 1,311 | 2,569 | 3,024 | 3,390 | 3,446 |
| Borrowings | 398 | 365 | 221 | 376 | 348 | 520 | 510 | 554 | 662 | 243 | 381 | 810 | 780 |
| Other Liabilities | 1,322 | 1,530 | 1,672 | 2,068 | 2,130 | 2,137 | 2,154 | 2,741 | 3,406 | 3,758 | 4,803 | 4,325 | 4,219 |
| Total Liabilities | 2,175 | 2,525 | 2,650 | 3,236 | 3,351 | 3,439 | 3,549 | 4,313 | 5,399 | 6,611 | 8,249 | 8,567 | 8,486 |
| Fixed Assets | 257 | 259 | 356 | 392 | 400 | 444 | 384 | 433 | 859 | 1,165 | 1,536 | 1,697 | 1,884 |
| CWIP | 22 | 16 | 34 | 25 | 41 | 67 | 72 | 152 | 83 | 127 | 123 | 137 | 73 |
| Investments | 36 | 242 | 11 | 13 | 15 | 17 | 295 | 162 | 148 | 267 | 432 | 457 | 548 |
| Other Assets | 1,860 | 2,007 | 2,250 | 2,806 | 2,895 | 2,911 | 2,799 | 3,565 | 4,309 | 5,053 | 6,158 | 6,276 | 5,981 |
| Total Assets | 2,175 | 2,525 | 2,650 | 3,236 | 3,351 | 3,439 | 3,549 | 4,313 | 5,399 | 6,611 | 8,249 | 8,567 | 8,486 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 215 | 257 | 159 | 19 | 258 | 450 | 350 | 87 | 247 | 289 | 688 | 154 |
| Investing | −49 | −48 | 69 | −88 | −65 | −81 | −238 | −67 | −179 | −524 | −463 | −354 |
| Financing | −190 | −195 | −203 | 51 | −181 | −167 | −70 | −82 | −91 | 365 | −162 | 137 |
| Net Cash Flow | −24 | 13 | 25 | −18 | 13 | 202 | 42 | −62 | −22 | 130 | 63 | −63 |
| Free Cash Flow | 180 | 208 | 52 | −73 | 180 | 369 | 367 | −131 | 65 | −144 | 319 | −169 |
| CFO/EBITDA | 143 | 173 | 70 | 24 | 84 | 189 | 150 | 36 | 68 | 64 | 99 | 35 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82 | 76 | 78 | 75 | 78 | 57 | 69 | 72 | 71 | 74 | 60 | 63 |
| Inventory Days | 79 | 104 | 97 | 152 | 119 | 116 | 143 | 125 | 124 | 106 | 131 | 131 |
| Days Payable | 146 | 211 | 191 | 228 | 211 | 211 | 260 | 223 | 217 | 198 | 209 | 177 |
| Cash Conversion Cycle | 15 | −31 | −16 | −2 | −14 | −38 | −48 | −26 | −22 | −18 | −18 | 16 |
| Working Capital Days | −12 | −17 | 6 | 8 | 8 | −13 | −1 | 6 | 4 | 20 | 16 | 20 |
| ROCE % | 15% | 20% | 20% | 20% | 25% | 19% | 13% | 20% | 24% | 26% | 26% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Blue Star insights
68 extracted metrics across FY11–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- 29 Oct 2026
- 29 Jan 2026
- 23 Sep 2026
- 7 Jul 2026
- 23 Sep 2025
- 8 Jul 2025
- 2 Dec 2024
- General announcements 16 Nov 2026
- General announcements 3 Nov 2026
- General announcements 30 Oct 2026
- General announcements 30 Oct 2026
Frequently Asked Questions about Blue Star
What does Blue Star Ltd do?
Where is Blue Star Ltd (BLUESTARCO) listed?
Which sector does Blue Star Ltd belong to?
What is the market capitalisation of Blue Star Ltd?
What is the PE ratio of Blue Star Ltd?
What is the 52-week high and low of Blue Star Ltd?
Does Blue Star Ltd pay dividends?
What is the Return on Equity (ROE) of Blue Star Ltd?
Company Information
Blue star manufacturers air purifiers, air coolers, water purifiers, cold storage and speciality products. The Company offers turnkey solutions in MEP (Mechanical, Electrical, Plumbing, and Fire-fighting) Projects. It is the largest after-sales service provider for air conditioning and commercial refrigeration products in the country.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BLUESTARCO.md for Blue Star Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.